Related references
Note: Only part of the references are listed.Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
Vesselina G. Cooke et al.
CANCER CELL (2012)
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
Rochelle R. Arvizo et al.
CHEMICAL SOCIETY REVIEWS (2012)
USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
Pieter J. A. Eichhorn et al.
NATURE MEDICINE (2012)
EMT as the ultimate survival mechanism of cancer cells
Neha Tiwari et al.
SEMINARS IN CANCER BIOLOGY (2012)
Estrogen-Related Receptor Gamma Promotes Mesenchymal-to-Epithelial Transition and Suppresses Breast Tumor Growth
Claire Tiraby et al.
CANCER RESEARCH (2011)
Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge
Rochelle R. Arvizo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Jones T. Nauseef et al.
NATURE REVIEWS UROLOGY (2011)
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
Sven Mahner et al.
BMC CANCER (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond
Rochelle R. Arvizo et al.
NANO LETTERS (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
Sanjib Bhattacharyya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic
Angeliki Voulgari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Minghai Shao et al.
CANCER RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
Beyond chemotherapy: targeted therapies in ovarian cancer
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2009)
Biological properties of naked metal nanoparticles
Resham Bhattacharya et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent
Chitta Ranjan Patra et al.
CANCER RESEARCH (2008)
Role of Hedgehog Signaling in Ovarian Cancer
Resham Bhattacharya et al.
CLINICAL CANCER RESEARCH (2008)
Early events in the pathogenesis of epithelial ovarian cancer
Charles N. Landen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells
Helen L. Spencer et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells
Jennifer J. Schumacher et al.
CANCER RESEARCH (2007)
Integration of TGF-β and Ras/MAPK signaling through p53 phosphorylation
Michelangelo Cordenonsi et al.
SCIENCE (2007)
Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail
Stefan Grotegut et al.
EMBO JOURNAL (2006)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Gold nanoparticles: a new X-ray contrast agent
JF Hainfeld et al.
BRITISH JOURNAL OF RADIOLOGY (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
Antiangiogenic properties of gold nanoparticles
P Mukherjee et al.
CLINICAL CANCER RESEARCH (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions
F Palacios et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro
X Lu et al.
NEOPLASIA (2004)
Gold nanoparticles inhibit VEGF165-induced proliferation of HUVEC cells
R Bhattacharya et al.
NANO LETTERS (2004)
Targeting the TGFβ signaling network in human neoplasia
N Dumont et al.
CANCER CELL (2003)
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer
PM Siegel et al.
NATURE REVIEWS CANCER (2003)
Angiogenesis in epithelian ovarian cancer
ES Bamberger et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2002)
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
D Liu et al.
CANCER CELL (2002)
Share Paper
